CN Patent

CN111465412A — Nk-1拮抗剂的口服药物组合物

Assigned to Intervet International BV · Expires 2020-07-28 · 6y expired

What this patent protects

一种包含telmapitant、非水性溶剂和一种或多种其他药学上可接受的赋形剂的口服药物组合物，其中telmapitant在组合物中处于溶解状态。一种治疗或预防动物呕吐的方法，包括施用口服药物组合物。

USPTO Abstract

一种包含telmapitant、非水性溶剂和一种或多种其他药学上可接受的赋形剂的口服药物组合物，其中telmapitant在组合物中处于溶解状态。一种治疗或预防动物呕吐的方法，包括施用口服药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111465412A
Jurisdiction
CN
Classification
—
Expires
2020-07-28
Drug substance claim
No
Drug product claim
No
Assignee
Intervet International BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.